NOS2 and Cerebral ischemia: In vivo experiments also showed that wogonin treatment protected against brain damage by reducing the production of inflammatory mediators, e.g., tumor necrosis factor (TNF)-α and iNOS, preventing the death of hippocampal neurons in cerebral ischemia [11], and inhibiting the activation of microglia in excitotoxic brain injury [11].